Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny ...
When the amount of cholesterol in the blood is too high, hypercholesterolemia can develop, causing serious damage to the arteries and cardiovascular health. Now, a study led by the University of ...
Scientists at UC San Francisco have discovered how pancreatic cancer cells thrive in the lungs or liver, environments that are as distinct to cells as the ocean and desert are to animals. The spread ...
Verve Therapeutics Inc (NASDAQ:VERV) on Monday released initial data from the Heart-2 Phase 1b trial of VERVE-102 in patients with heterozygous familial hypercholesterolemia (HeFH) and/or premature ...
A protein called PCSK9 determines how pancreatic cancer cells metastasize to different parts of the body. Scientists at UC San Francisco have discovered how pancreatic cancer cells thrive in the lungs ...
Merck has unveiled a groundbreaking cholesterol-lowering pill, enlicitide, which could transform treatment for millions of Americans struggling with high LDL cholesterol. The once-daily oral ...
Single infusion of VERVE-102 led to dose-dependent decreases in blood PCSK9 and LDL-C, with mean reduction in LDL-C of 53% and a maximum reduction of 69% observed in the 0.6 mg/kg dose cohort ...
Pfizer has been working on developing an oral pill and vaccine that will target PCSK9, the protein that maintains LDL or “bad” cholesterol in the bloodstream, according to a Reuters report. The ...
Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an effective alternative to injections of PCSK9 inhibitors to lower low-density ...
The PCSK9 inhibitor market is gaining significant traction as healthcare systems worldwide prioritize advanced treatments for hypercholesterolemia and cardiovascular disease prevention. PCSK9 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results